A recent outbreak of the Nipah virus in India has triggered heightened concern among several Asian nations, especially considering the virus’s high fatality rate, which can range from 40% to 75% in humans.
Countries like Thailand, Malaysia, and Singapore have implemented new screening and testing protocols following the reported deaths of at least two individuals in West Bengal, India, this month due to the virus.
So, what exactly is the Nipah virus and how serious is the situation?
What is Nipah virus?
Nipah belongs to a category of viruses known as henipaviruses, similar to the Hendra virus. It’s zoonotic, which means it can be transmitted from animals to humans.
Outbreaks have occurred sporadically in Asia, with the first being recorded in Malaysia back in 1998. The virus spreads primarily in three ways.
The first method is through exposure to bats, specifically by coming into contact with their saliva, urine, or feces. Infections can also take place through contact with other infected animals, like pigs, which were involved in the initial Malaysian outbreak.
The second transmission route is through contaminated food, particularly products derived from date palms, such as juice or sap that has come into contact with infected bat fluids.
Lastly, human-to-human transmission is possible but reported less frequently, typically occurring via close contact, like taking care of an infected individual.
What are the symptoms?
Symptoms of Nipah virus infection can appear quickly, usually between four days to three weeks after exposure. It’s a serious illness, with around half of those with severe infections succumbing to it.
The severity of symptoms can vary. Nipah might lead to pneumonia, much like COVID-19 does, but the more frightening aspect is its potential to cause severe neurological symptoms, including encephalitis, or inflammation of the brain.
This brain involvement is a key reason for the high fatality rate. Common symptoms may include:
- Fever
- Seizures
- Difficulty breathing
- Loss of consciousness
- Severe headaches
- Inability to move a limb
- Jerky movements
- Personality changes, which could manifest as odd behavior or psychosis.
Interestingly, some survivors of the acute phase may experience relapsed encephalitis years later, occasionally even a decade after the initial infection.
Is there any treatment or vaccine?
Currently, no specific treatment or vaccine exists for Nipah virus. However, Australia is working on a treatment called m102.4. A phase 1 trial conducted in 2020 showed that the treatment was well tolerated in healthy participants, but it’s still a long way from being widely available for those infected with Nipah.
In theory, m102.4 might serve as a preventive measure, although right now, it is primarily being investigated as a treatment option.
How worried should I be?
The current Nipah outbreak in India raises concern due to the absence of preventive measures and effective treatments, and because it is a severe disease. However, it doesn’t appear to pose the same level of public health risk as COVID-19.
This is largely because Nipah doesn’t spread easily from person to person, with the main transmission pathways being through food or infected animals.
For those living outside of affected regions, the risk remains low. Even in regions with reported cases, the number is still relatively small, and health authorities are taking necessary precautions.
If you start feeling unwell after visiting areas with reported cases, it’s advisable to inform your healthcare provider about your travel history. If someone develops a fever after traveling to these affected regions, it’s generally more concerning if it’s due to other diseases like malaria or typhoid rather than Nipah.
Overall, while Nipah is significant for the countries experiencing outbreaks, for many others, it remains something to watch closely rather than panic over.
